Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience.
Manu
M
M
Department of Urology, Tokyo Women's Medical University, Section of Renal Transplantation/Renovascular Surgery, Kidney Center, Tokyo, Japan.
Tanabe
K
K
Tokumoto
T
T
Ishikawa
N
N
Shimizu
T
T
Okuda
H
H
Ito
S
S
Shimmura
H
H
Inui
M
M
Harano
M
M
Shiroyanagi
Y
Y
Yagisawa
T
T
Fuchinoue
S
S
Toma
H
H
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000453:epidemiology / Q000209:etiology; D006949:Hyperlipidemias / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D015228:Hypertriglyceridemia / Q000453:epidemiology / Q000209:etiology; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015994:Incidence; D007564:Japan; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D011183:Postoperative Complications; D012189:Retrospective Studies; D012263:Ribonucleosides / Q000627:therapeutic use; D012307:Risk Factors; D016559:Tacrolimus / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; D014280:Triglycerides; C010052:mizoribine; D016572:Cyclosporine; D002784:Cholesterol; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone